-
BI 2536 for Reliable PLK1 Assays
2026-08-26
Learn how BI 2536 (SKU A3965) can support better-designed cell viability, proliferation, cytotoxicity, and cell-cycle experiments. This practical guide connects PLK1 biology with stock preparation, endpoint selection, data interpretation, and vendor evaluation.
-
Deferoxamine Mesylate: Iron Stress Workflow
2026-08-26
Deferoxamine mesylate provides a practical way to manipulate labile iron, oxidative stress, and hypoxia signaling in cell and tissue models. This workflow guide shows how to use it as a mechanistic control for ferroptosis, HIF-1α stabilization, wound healing promotion, and cancer-related assays without confusing chelation effects with direct cytotoxicity.
-
AICAR Phosphate: AMPK to Translational Apoptosis
2026-08-25
A mechanistic and strategic guide to using AICAR phosphate (Acadesine) to connect AMPK signaling with mitochondrial apoptosis in B-CLL research, while assessing how emerging neuroimmune findings may inform—but not yet validate—future translational applications.
-
CHIR 99021: Tuning Organoid Stemness
2026-08-25
A translational framework for using CHIR 99021 trihydrochloride to interrogate GSK-3 biology, tune organoid self-renewal and differentiation, and connect stem-cell systems with insulin signaling and metabolic disease research.
-
Cyclo (-RGDfC): From Binding Probe to Assay Design
2026-08-24
Cyclo (-RGDfC) is a cyclic RGD probe for αvβ3 integrin research. This guide connects receptor targeting with assay design, endpoint selection, and lessons from canine osteosarcoma viability research.
-
RITA (NSC 652287): From p53 Mechanism to Translation
2026-08-24
RITA (NSC 652287) offers translational researchers a way to connect MDM2-p53 pathway activation, DNA cross-link biology, cell-death measurement, and tumor xenograft evidence. This thought-leadership framework explains how to evaluate its reported activity without confusing growth inhibition with cell killing or preclinical promise with clinical validation.
-
Myriocin Reverses dAGE-Driven Metabolic Dysfunction
2026-08-23
This 2025 Nutrients study identifies sphingolipid synthesis inhibition as a potential strategy for correcting diet-derived advanced glycation end product–associated metabolic dysfunction. In mice, Myriocin improved body-weight gain, hepatic steatosis, glucose handling, circulating lipids, mitochondrial biogenesis, and adipose thermogenesis through coordinated AMPK–PGC1α signaling.
-
Doxorubicin Hydrochloride: Practical Assay Workflows
2026-08-22
Build reproducible Doxorubicin hydrochloride experiments across cancer-cell screening, apoptosis assay design, dual-loaded liposome characterization, and cardiotoxicity models. This guide combines dose-planning, analytical separation, controls, and troubleshooting so Adriamycin HCl data remain interpretable from bench assay to preclinical study.
-
Quercetin Beyond PI3K: From Apoptosis to Ferroptosis
2026-08-22
Quercetin is more than a familiar dietary flavonoid: it is a mechanistically broad research tool linking PI3K signaling, mitochondrial apoptosis, inflammation, lipid peroxidation, and ferroptosis. A recent Wilson disease study provides a valuable translational case study, showing how quercetin may protect injured liver tissue by engaging the ACSL4/LPCAT3/ALOX15 axis. This article translates those findings into a rigorous framework for cancer research, liver injury models, pathway validation, and reproducible compound deployment.
-
Norovirus Co-opts NINJ1 for Selective NS1 Secretion
2026-08-21
Song et al. show that murine norovirus uses the host membrane-rupture factor NINJ1 to release the viral immune-modulatory protein NS1 through an unconventional secretion route. The study combines CRISPR screening, caspase-3 perturbation, microscopy, viral-protein mutagenesis, and mouse infection experiments to connect selective NS1 release with enteric infection.
-
Diclofenac in Human Intestinal Organoid Workflows
2026-08-20
Learn how to use Diclofenac as a non-selective COX inhibitor in human iPSC-derived intestinal organoids while separating intestinal exposure, metabolism, and prostaglandin-linked pharmacodynamics. The workflow combines practical dosing, assay controls, and troubleshooting guidance for translational inflammation and pharmacokinetic studies.
-
Capsazepine: TRPV1 Ion Channel Antagonist Guide
2026-08-20
Capsazepine enables controlled dissection of TRPV1-driven calcium signaling, nociception, and channel cross-reactivity in cellular and translational assays. This workflow-focused guide covers solvent handling, concentration design, assay controls, TRPM8 comparisons, and apoptosis sensitization applications.
-
p-Cresyl Sulfate in CKD Cardiovascular Research
2026-08-19
p-Cresyl sulfate, also called p-tolyl hydrogen sulfate, is a protein-bound uremic solute relevant to chronic kidney disease and cardiovascular research. Current evidence links it to impaired endothelial repair and enhanced valvular interstitial cell calcification, while product handling requires cold storage and freshly prepared solutions.
-
E. coli Uracil-DNA Glycosylase (UDG) Guide
2026-08-19
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA to support PCR product contamination elimination and DNA damage repair research. It is intended for research workflows involving DNA, not RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-08-18
The Hoechst 33342/PI Double Staining Kit provides a dual-fluorescence workflow for distinguishing normal, apoptotic, and membrane-compromised cells by combining nuclear staining with PI uptake. It is intended for research cell-death analysis and assay development, not for diagnostic or medical use.